Received Sep 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | JE9PP | — |
inadvertent administration of an Expired dose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 1-year-old male patient who received MMR (Priorix) (batch number JE9PP, expiry date 01-SEP-2025) for prophylaxis. On 05-SEP-2025, the patient received Priorix. On 05-SEP-2025, an unknown time after receiving Priorix, the patient experienced expired vaccine used (Verbatim: inadvertent administration of an Expired dose). The outcome of the expired vaccine used was not applicable. It was unknown if the reporter considered the expired vaccine used to be related to Priorix and Priorix Pre-Filled Syringe Device. It was unknown if the company considered the expired vaccine used to be related to Priorix and Priorix Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 05-SEP-2025 The health care provider together with a nurse called to report the inadvertent administration of an expired dose of Priorix vaccine to the patient, which led to expired vaccine used. They wanted to know how to proceed after the incident and if the dose should be considered valid or repeat it. The vaccine administration facility was the same as primary reporter.